Hervé Ghesquières
0000-0002-3131-3718
4 papers found
Refreshing results…
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell–Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial
Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study
Real‐life targeted next‐generation sequencing for lymphoma diagnosis over 1 year from the French Lymphoma Network
BeEAM (bendamustine, etoposide, cytarabine, melphalan) prior to autologous stem cell transplant for chemosensitive relapses in patients with follicular lymphoma: a prospective multicentre phase II study in Lymphoma Study Association centres †
Missing publications? Search for publications with a matching author name.